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For several years radiation beams have been
modulated by mechanical and dynamie wedges,
compensators, individual shields and unequal
beam weights. Nowadays three dimensional
conformai treatment and intensity modulated
radiation therapy techniques (IMRT) provide
very precise conformation of the dose to the
target volume while sparing adjacent healthy
tissues. On the other hand conformal
radiotherapy requires very precise definition of
anatomical structures, improved patient
repositioning systems. New challenge
represents quality control program and
treatment verification.
IMRT was introduced in c1inical practice in
Center of Oncology, Gliwice in year 2000. Such
treatment is delivered by Clinac 2300 with
dynamic MLC option, on the base of dose
distributions calculated by CadPlan-Helios
treatment planning system, and sent via Varis to
accelerator.
The aim of this paper is to present our
experience with IMRT technique with particular
regard to IMRT treatment plan (definition of PTV
and calculation factors like Termination
Tolerance, Priority Factor, Scatter Factor).
8.
EVALUATION OF A NEW SYSTEM
FOR IN-VIVO DOSIMETRY BASED ON
MOSFET DETECTORS
P.F. Kukołowicz, K. Buliński, K. Lis,
J. Miedzińska
Holycross Cancer Centre, Medical Physics
Department, Kielce, Poland
Purpose: In Holycross Cancer Centre in
Kielce in vivo dosimetry is performed with new
miniature detectors called MOSFET. MOSFETs
are advertised by Thomson &Nielsen company
as almost ideal detector for in-vivo dosimetry:
they are isotropie, can be treated as point
detector fully transparent to treatment beam,
having zero temperature and negligible energy
effect, can be used either for electron and
photon radiation, in teletherapy and
brachytherapy, can be used in sęveral QA
procedures, very easy and convenient for
handling and very low time consuming. Our
experience both from extensive tests and clinical
use will be presented.
Results: From our experience MOSFETs
detectors can be treated as isotropie, are fully
transparent for radiation, can be used both in
teletherapy and brachyterapy. For application in
3D
brachyterapy special catheters with lead
localisation markers must be used. The energy
dependence cannot be considered as negligible.
For 6 and 15 MV X photons calibration factors
differ of about 5%. Reproducibility depends
strongly on the dose. It decreases very much for
very smali doses (for dose 60 cGy - 1 standard
deviation is of 2,5%). Very useful advantage of
MOSFET detectors is their applicability for
surface dose measurements. More details will
be presented during the congress.
Conclusion: MOSFET detectors can be
effectively used for in-vivo dosimetry in tele and




TIONAL SIMULATOR PLANNING AND
CONFORMAL 3-D PLANNING FOR
CERVICAL CANCER TELETHERAPY
K. Bratos, A. Roszak, E. Cikowska-Woźniak,
T.Piotrowski
Wielkopolskie Centrum Onkologii, Poznań,
Poland
The using of simulator planning based on
bony landmarks for pelvic irradiation of cervix
cancer is associated with a risk in a
geographical miss, which may be generated by
inadequate knowledge of the individual
anatomy. 3D treatment planning system let us
know an individual topography of pelvic organs,
enables to mark a PTV and it allows more
adequate coverage. PURPOSE The aim of this
study was to evaluate a benefit resulting from
3D treatment planning for teletherapy of cervical
cancer. MATERIAL AND METHOD In our study
on 15 patients with cervical carcinoma in the
stage IIIB simulator planning of "box" technique
was performed. Next we defined the PTV in 3D-
planning system and compared the dose
distribution, obtained with both methods, in the
target volumes and organs at risk using dose-
volume histograms. RESULTS In 4 of 15
patients the encompassment of the PTV by the
treated volume was inadequate in case of
simulator planning. The treated volumes based
on 3D-planning were 8% smaller than volumes
based on simulator planning. The treated
volume/ planning target volume ratio was 1,64
for simulator planning and 1,50 for 3D planning.
3D-planning system resulted in a reduction of
the irradiated bladder volume(-12%) and the
bowel volume (-9%). The bladder and bowel
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volumes in treated volumes depended on
bladder fillings. CONCLUSIONS Implementation
of 3D treatment planning system in teletherapy
of cervical cancer helps to avoid a geographical
miss, to reduce both the treated volume and the
doses delivered to organs at risk.
10.
THE COMPARISON BETWEEN THE
THREE - FIELD AND FOUR-FIELD
TECHNIQUES OF PLANNING OF
RADIOTHERAPY IN PROSTATE
CANCER
P. Milecki, T. Piotrowski, M. Dymnicka,
J. Malicki, G. Stryczyńska
Greatpoland Cancer Centre, Poznań, Poland
Purpose: evaluation 3-field(3F) and 4-field(4F)
planning techiniques for patients with localized
prostate cancer. Materials/methods: Five
patients with prostate cancer (T3NOMO) were
evaluated. CT images were obtained at 5mm
increments and were transferred to
CadPlan_planning_workstation. The planning
target volume (PTV) was detined as prostate
and seminal vesicles with 15mm margins
around c1inical target volume (CTV) except
prostate-rectum interface where 5mm margin
was applied. CTV was detined as prostate and
seminal vesicles.Following organs at risk (CAR)
were outlined: rectum, bladder, right temaral
head. Following 3F and 4F plans were
performed: 3F with angles (Odeg-120deg-
240deg; Odeg-90deg-270deg) and 4F (Odeg-
90deg-180deg-270deg). We also created two
versions ot treatment plans including ot energy;
6MV and 20MV for Clinac2300CD. Total dose
was 74Gy. Mean total doses ot thirty plans in
irradiated organs at risk (rectum, bladder and
righ temoral head) were compared. For PTV
mean and minimum dose were criteria tor
comparision ot treatment plans. Results: There
were no significant dose differenes between
evaluated plans ot treatment in PTV(0.05).
Secause mean dose in femoral head in each
treatment plan was below tolerance dose, main
dose-Iimiting organ was rectum and bladder.
Lowest mean dose 42.7 Gy in rectum was
achived by application ot 3F technique ot
20MV(Odeg-90deg-270deg). SIadder was also
spared with the same 3F technique of 20MV,
where mean dose was 45.2Gy. Conclusions:
This study showed that the "T" three-tield
technique (an anterior and two opposing lateral
tields) provided with 20 MV is optimal and
assures the lowest rectal dose.
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THE ANALYSIS OF DOSES IN THE
TUMOUR AND IN CRITICAL TISSUES
IN THE BRACHYTHERAPY OF
MALIGNANT MELANOMA LOCALlSED
IN EYES
J. Kierzkowski1, J. Malicki1, A. Roszak2
l Medical Physics Department and 2Srachytherapy
Ward, Greatpoland Cancer Centre, Garbary 15
Street, 61-866 Poznań, Poland.
Srachytherapy is known and used procedure
in the treatment of tumours localised in eyes,
especially recommended when avoiding ot
enucleation accompany the long term cure.
Aim: The aim ot this paper was to compare
the doses delivered to the tumour and critical
tissues during the treatment of the group ot
patients treated with Ru-106 applicator.
Patients: Setween 1994 and 2000, 67
patients (dgn. melanoma malignum in eye)
underwent brachytherapy. At 51 patients the
tumour was localized in the back ot eye, at 15
equatorially and at one in the tront section ot the
eyeball. The median ot the patients' age was
56.3 years. The CCS type applicator was
applied for 56 patients, the COS for 7 and the
ROA tor 4 patients.
Method: Irradiation - Prescribed dose of 60
Gy was normalized to the top ot the tumour, it
decreased by 50%-10% per millimetre with the
distance trom applicator. The isotope producer
determined the dose-rate accuracy tor +/-30%.
This caused that therapeutic dose had to be
calculated taking account tor the minimai dose-
rate, while the doses in critical organs for
maximai dose-rate possible.
Analysis: Ali patients were divided into three
subgroups: 8 patients into 1sI , 19 into 2nd and 40
into 3rd • The inclusion criterion was size of
tumour: up to 3 mm of height (1 S1 group), 3-5
mm (2nd), and larger than 5 mm (3rd)
respectively.
Results: Table presents mean doses in the
tumour, selera and lens (calculated at it's
middle) tor each group ot patients.
Tumour Doses [Gy]
size
[mm] Tumour Selera lens
<3 102.9 162.4 137.6
3-5 186.2 463.5 396.2
>5 268.2 974.9 840.6
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